365 related articles for article (PubMed ID: 10403079)
1. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
Zipursky A; Brown EJ; Christensen H; Doyle J
Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
[TBL] [Abstract][Full Text] [Related]
2. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
[TBL] [Abstract][Full Text] [Related]
3. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
4. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
5. Hematological disorders in Down syndrome: ten-year experience at a Tertiary Care Centre in North India.
Awasthi A; Das R; Varma N; Ahluwalia J; Gupta A; Marwaha RK; Garewal G
Pediatr Hematol Oncol; 2005 Sep; 22(6):507-12. PubMed ID: 16169817
[TBL] [Abstract][Full Text] [Related]
6. Down syndrome and leukemia--an overview of cytogenetic and molecular events.
Savaşan S; Taub JW; Ravindranath Y
Turk J Pediatr; 1997; 39(4):519-31. PubMed ID: 9433155
[No Abstract] [Full Text] [Related]
7. [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].
Wacker A; Scheel-Walter HG; Neunhoeffer F
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):64-6. PubMed ID: 19319796
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.
Dixon N; Kishnani PS; Zimmerman S
Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):149-57. PubMed ID: 17048354
[TBL] [Abstract][Full Text] [Related]
9. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.
Gamis AS; Smith FO
Br J Haematol; 2012 Nov; 159(3):277-87. PubMed ID: 22966823
[TBL] [Abstract][Full Text] [Related]
10. Congenital leukaemia in Down Syndrome--a case report.
Aier M; Zadeng T; Basu D; Biswal N; Nalini P
Indian J Pathol Microbiol; 2002 Jul; 45(3):355-7. PubMed ID: 12785186
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
Hendricks SK; Sorensen TK; Baker ER
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine diagnosis and management of transient myeloproliferative disorder.
Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
[TBL] [Abstract][Full Text] [Related]
14. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
15. [Transient myeloproliferative syndrome or congenital leukemia in a newborn infant with Down syndrome?].
Maszkiewicz W; Zarczynska B; Koralewska J
Wiad Lek; 1989 May; 42(10):685-8. PubMed ID: 2534337
[TBL] [Abstract][Full Text] [Related]
16. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
17. Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome.
Chopra A; Kumar R; Kabra M; Anand M
Platelets; 2008 Mar; 19(2):160-1. PubMed ID: 18297553
[No Abstract] [Full Text] [Related]
18. Clinicopathological features of transient myeloproliferative syndrome and congenital leukaemia.
Sajid N; Ahmed N; Mahmood S
J Coll Physicians Surg Pak; 2010 Sep; 20(9):576-80. PubMed ID: 20810047
[TBL] [Abstract][Full Text] [Related]
19. A newborn with Down syndrome-transient myeloproliferative disorder.
Akdag A; Tunç B; Oğuz S; Dilli D; Dilmen U
J Perinat Med; 2010 Jul; 38(4):445-7. PubMed ID: 20443668
[No Abstract] [Full Text] [Related]
20. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders.
Nijhawan A; Baselga E; Gonzalez-Ensenat MA; Vicente A; Southern JF; Camitta BM; Esterly NB; Drolet BA
Arch Dermatol; 2001 Jun; 137(6):760-3. PubMed ID: 11405767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
